Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$0.36 - $0.65 $4,500 - $8,125
-12,500 Reduced 50.0%
12,500 $4,000
Q3 2023

Nov 21, 2023

BUY
$0.58 - $1.47 $14,499 - $36,750
25,000 New
25,000 $15,000
Q3 2021

Nov 22, 2021

SELL
$9.01 - $12.01 $29,129 - $38,828
-3,233 Reduced 20.55%
12,500 $112,000
Q2 2021

Aug 26, 2021

SELL
$10.17 - $12.64 $4,352 - $5,409
-428 Reduced 2.65%
15,733 $188,000
Q1 2021

Apr 28, 2021

SELL
$10.88 - $17.05 $4,319 - $6,768
-397 Reduced 2.4%
16,161 $202,000
Q1 2020

May 01, 2020

BUY
$5.05 - $8.85 $2,070 - $3,628
410 Added 2.54%
16,558 $105,000
Q3 2019

Oct 31, 2019

BUY
$9.05 - $12.22 $2,208 - $2,981
244 Added 1.53%
16,148 $146,000
Q4 2018

Feb 06, 2019

SELL
$9.51 - $16.6 $323 - $564
-34 Reduced 0.21%
15,904 $177,000
Q2 2018

Aug 01, 2018

BUY
$13.9 - $19.8 $7,353 - $10,474
529 Added 3.43%
15,938 $241,000
Q1 2018

May 01, 2018

SELL
$16.7 - $26.35 $1,469 - $2,318
-88 Reduced 0.57%
15,409 $296,000
Q3 2017

Nov 06, 2017

BUY
$8.4 - $15.0 $130,174 - $232,455
15,497
15,497 $196,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $180M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.